To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)

The requested reference [9ba366aa3695e849d5f3f44921cda56071ac6218] no longer exists in our database. It has been replaced by the current reference: [f7d666f89038033535c9636c8365e10a8ae8808d]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
Prospective, interventional, open, randomized, national, multicenter, non-commercial trial
Epistemonikos ID: 3f9f670b4734df6d6558184bb895f6936b2ec54b
First added on: May 15, 2024